securities fraud

Trip.com faces securities investigation following Chinese antitrust probe. Stock dropped 17% after disclosure; investors may pursue class action lawsuit for alleged misleading disclosures.

Robbins Geller sues Richtech Robotics for misrepresenting Microsoft partnership scope. Stock fell 29% after Microsoft clarified relationship was limited to AI lab, not commercial deal.

Rosen Law Firm files securities class action against Inovio Pharmaceuticals for allegedly making false statements about manufacturing deficiencies and regulatory prospects between October 2023 and December 2025.

Class action lawsuit filed against China Liberal Education over alleged pump-and-dump scheme involving fake investment advisors on social media that artificially inflated stock prices.

Securities class action filed against Kyndryl for false disclosures. Investors who purchased stock August 2024-February 2026 can claim damages; lead plaintiff deadline April 13, 2026.

Law firm investigates Ramaco Resources for alleged securities fraud over inactive Wyoming mine despite reported groundbreaking. Class action deadline: March 31, 2026.

Pomdoctor investors must act by April 13, 2026, to join securities fraud class action alleging false statements and manipulated trading volumes that caused stock decline.

Rosen Law Firm investigates Nidec over accounting irregularities in China operations. Stock plunged 22.7% following disclosure of management-related accounting issues.

Law firm sues REGENXBIO for allegedly hiding safety concerns about gene therapy RGX-111. Stock dropped 17.8% after FDA clinical hold due to tumor in trial participant.

Rosen Law Firm sued uniQure for allegedly misleading investors about FDA approval timelines and regulatory study status between September-October 2025.

KDDI delays Q3 earnings report due to internal investigation, causing ADR stock to plunge 11.4%. Securities firms examine potential investor claims over disclosure accuracy.

Rosen Law Firm sues Picard Medical for securities fraud involving false statements and market manipulation. Investors must act by April 13, 2026 deadline.

Ultragenyx faces class action lawsuit alleging false statements about its osteogenesis imperfecta drug's efficacy after Phase III trial failed to meet primary endpoint.

Robbins LLP sues Masonite for allegedly hiding Owens Corning acquisition talks while repurchasing 270,000 shares at discounted prices. Lead plaintiff deadline April 7, 2026.

Class action lawsuit filed against Picard Medical for alleged securities fraud involving false statements and share price manipulation during fall 2025. Investors who purchased shares during this period may be eligible for damages.

Inovio Pharmaceuticals faces class action lawsuit for allegedly misleading investors about device manufacturing capabilities and regulatory delays, leading to 24% stock decline.

Robbins LLP files class action against Paysafe Limited for alleged misrepresentations about client risk and financial guidance. Stock fell 27.6% in November 2025.

Oracle faces securities fraud class action for allegedly misleading investors about AI infrastructure investments requiring substantial capital with minimal near-term revenue generation.

Schall Law Firm recruits lead plaintiffs for securities fraud class action against Masonite, alleging false statements and improper share buybacks during June 2023-February 2024.

Paysafe faces securities fraud lawsuit for allegedly making false statements about client risk exposure and understating credit loss reserves during March-November 2025.